Cart
sales@molnova.com
Taurolidine
CAS No. 19388-87-5
Taurolidine( —— )
Catalog No. M20835 CAS No. 19388-87-5
Taurolidine is a synthetic taurine analog with antimicrobial and anti-neoplastic actions.?It displays broad bactericidal and fungicidal activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 42 | Get Quote |
|
| 50MG | 67 | Get Quote |
|
| 100MG | 102 | Get Quote |
|
| 200MG | 151 | Get Quote |
|
| 500MG | 255 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTaurolidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionTaurolidine is a synthetic taurine analog with antimicrobial and anti-neoplastic actions.?It displays broad bactericidal and fungicidal activity.
-
DescriptionTaurolidine is a synthetic taurine analog with antimicrobial and anti-neoplastic actions.?It displays broad bactericidal and fungicidal activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaCancer
-
IndicationColorectal Cancer; Periodontitis
Chemical Information
-
CAS Number19388-87-5
-
Formula Weight284.36
-
Molecular FormulaC7H16N4O4S2
-
Purity>98% (HPLC)
-
SolubilityDMSO:56mg/mL(196.93mM)
-
SMILESO=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mccourt M Wang J H Sookhai S et al. Taurolidine Inhibits Tumor Cell Growth In Vitro and In Vivo[J]. Annals of Surgical Oncology 2000 7(9):685-691.
molnova catalog
related products
-
NAV-2729
NAV-2729 inhibits six ArfGEFs (human ARNO, EFA6, BIG1, and BRAG2 and Legionella and Rickettsia RalF), the strongest effects being against BRAG2, Arf1 and Arf6.
-
Puerarin-4-O-β-D-glu...
Puerarin-4'-O-β-D-glucopyranoside is a natural product isolated from Pueraria lobata root having estrogenic activity and anti-proliferation in MCF-7 human breast carcinoma cells.
-
5-(5-methyl-1H-1,2,4...
5-(5-methyl-1H-1,2,4-triazol-3-yl)-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole can be used in the synthesis of heterocyclic compounds to inhibit HIF pathway activity.
